Journal Management System
ScopeMed is an
Online Journal/Article Management system
that can enable all of the operations of
the editorial functions of a journal.
Home  |   Add your Journal  |   Properties of ScopeMed  |   Video Tutorials  |   Journal List
Author Login | Reviewer Login | Editor Login
Search  


Journal of Molecular Pathophysiology
Periodical of GESDAV
Journal Home Page
ISSN: 2146-832X (Print)
Language: [ English ]  

  » Volume 1, Issue 1
      pp. 1-83

 

Open Access

Original Research



Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated

Nicholas P Booth, Wells Brockbank, Samuel Oh, Karl Kingsley.

A B S T R A C T 

Abstract
Objective: Oral cancers are slow developing tumors that affect thousands of individuals in the US annually. Evidence has shown that these cancers can create microenvironments to enhance their progression, survival and metastasis characteristics. Cancer cells will compete for extracellular nutrients with normal tissue cells, which can cause irregularities in immune regulation of progressive cancers. Recent evidence in other types of cancers have suggested that tumor cells may actually upregulate the consumption of extracellular L-tryptophan and increase the export of cytosolic kynurenine byproduct. These kynurenines have been linked to suppression of local immune response of T-cells. The primary goal of this study was to evaluate oral cancer cell lines for tryptophan dioxygenase (TDO) and Indolamine 2,3-dioxygenase (IDO) expression and elucidate whether or not other flavonoids inhibit enzyme expression and cancer growth. Methods: Oral cancer cell lines SCC25, SCC15, and CAL27 were screened for enzyme expression using mRNA specific primers and RT-PCR. The three cell lines were then subjected to proanthocyanidin (PAC) administration to determine potential growth and enzyme inhibition. Results: This study found that IDO and TDO are expressed in the SCC25, SCC15, and CAL27 oral cancer cell lines and enzyme expression is correlated with tumor growth. Additionally, it was observed that IDO and TDO expression, along with tumor growth, can be inhibited by flavonoid administration. Conclusions: With no real treatment advances in many years and survival rates remaining relatively unchanged, these results provide further knowledge in the understanding of oral cancer mechanisms and function that may lead to future treatment modalities. Our demonstration of enzyme down regulation and growth inhibition induced by flavonoids may also contribute to further research in future novel treatments.

Key words: Indoleamine 2,3-dioxygenase (IDO); Oral squamous cell carcinoma (OSCC); Tryptophan dioxygenase (TDO)


ARTICLE TOOLS
Abstract
PDF Fulltext
Email this Article
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Nicholas P Booth
Articles by Wells Brockbank
Articles by Samuel Oh
Articles by Karl Kingsley
on IndexScholar Fulltext
on Google
on Google Scholar
Article Statistics
 Viewed: 229
Downloaded: 129
(Last 7 Days: 0)
Cited: 0
Emailed: 0

How to Cite this Article
Pubmed Style

Booth NP, Brockbank W, Oh S, Kingsley K. Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated. J Mol Pathophysiol. 2012; 1(1): 29-36. doi:10.5455/jmp.20120609040915



Web Style

Booth NP, Brockbank W, Oh S, Kingsley K. Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated. www.scopemed.org/?mno=21379 [Access: May 23, 2013]. doi:10.5455/jmp.20120609040915



AMA (American Medical Association) Style

Booth NP, Brockbank W, Oh S, Kingsley K. Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated. J Mol Pathophysiol. 2012; 1(1): 29-36. doi:10.5455/jmp.20120609040915



Vancouver/ICMJE Style

Booth NP, Brockbank W, Oh S, Kingsley K. Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated. J Mol Pathophysiol. (2012), [cited May 23, 2013]; 1(1): 29-36. doi:10.5455/jmp.20120609040915



Harvard Style

Booth, N. P., Brockbank, W., Oh, S. & Kingsley, K. (2012) Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated. J Mol Pathophysiol, 1 (1), 29-36. doi:10.5455/jmp.20120609040915



Turabian Style

Booth, Nicholas P, Wells Brockbank, Samuel Oh, and Karl Kingsley. 2012. Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated. Journal of Molecular Pathophysiology, 1 (1), 29-36. doi:10.5455/jmp.20120609040915



Chicago Style

Booth, Nicholas P, Wells Brockbank, Samuel Oh, and Karl Kingsley. "Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated." Journal of Molecular Pathophysiology 1 (2012), 29-36. doi:10.5455/jmp.20120609040915



MLA (The Modern Language Association) Style

Booth, Nicholas P, Wells Brockbank, Samuel Oh, and Karl Kingsley. "Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated." Journal of Molecular Pathophysiology 1.1 (2012), 29-36. Print. doi:10.5455/jmp.20120609040915



APA (American Psychological Association) Style

Booth, N. P., Brockbank, W., Oh, S. & Kingsley, K. (2012) Indoleamine 2,3-dioxygenase (IDO) and tryptophan dioxygenase (TDO) mRNA expression in oral squamous cell carcinoma cells is actively and differentially modulated. Journal of Molecular Pathophysiology, 1 (1), 29-36. doi:10.5455/jmp.20120609040915




» Last Downloads

Please Wait...




Total Download: 1.595
(for Journal of Molecular Pathophysiology)
Total Submission during last 24 hours: 156


» For Authors




Become Reviewer


» Login Area




Follow ScopeMed on Twitter

ScopeMed Home | About ScopeMed | Contact Us | Terms & Conditions | Privacy Policy
The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of SAGE Publishing for Scientific Publications. Copyright © ScopeMed® International Medical Journal Management and Indexing System.